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AbstrAct
Pregnancy outcomes in patients on chronic dialysis have improved as a result of the intensification of dialysis and 
improved perinatal care. We report the successful outcome of a pregnancy in a patient on chronic haemodialysis in 
Cape Town, South Africa. With intensification of her therapy using thrice-weekly, nocturnal haemodialysis the 
pregnancy was maintained until 34 weeks at which time a 1.86 kg baby boy was delivered by elective caesarean 
section. One year later the patient was doing well on maintenance haemodialysis and the baby was achieving his 
developmental milestones. This report highlights our ability to employ a multi-disciplinary approach and prolonged, 
nocturnal haemodialysis to support pregnant dialysis patients in the South African setting and achieve good outcomes 
for both mother and baby.
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IntroductIon
The first successful pregnancy in a patient on chronic 
haemodialysis was reported by Confortini et al. in 
1971 [1]. Since then, live birth rates of pregnant dialysis 
patients have improved from around 20% in the 1980’s 
to 50% in the 2000’s and now exceed 80% [2-4]. The 
recent meta-analysis by Piccoli et al. [4] highlights the 
improving pregnancy outcomes in both haemo- and 
peritoneal dialysis patients. This encouraging trend has 
been achievable primarily through the intensification and 
increased duration of haemodialysis sessions and also by 
improved perinatal care. The introduction of prolonged 
nocturnal dialysis facilitates the ability to deliver more 
than 25 hours of haemodialysis weekly. Maternal mortality 
remains very high, however, 400 times that of the non-
dialysis population. It is estimated that pre-eclampsia 
affects more than 75% of pregnant haemodialysis patients.
In South Africa, it is uncommon for patients on chronic 
dialysis to have successful pregnancies, although col-
leagues from around the country have indicated that 
they have had occasional patients with good outcomes. 
To the best of our knowledge, none of these cases have 
been formally published. Here, we report the successful 
outcome of a pregnancy in a patient on chronic haemo-
dialysis in Cape Town, South Africa. The patient provided 
written consent for publication.
cAse presentAtIon
A 27-year-old woman with end-stage renal disease due 
to systemic lupus erythematosus had her first living-
related kidney transplant at the age of 20 years. When 
this failed, she subsequently underwent a second 
deceased-donor transplant at age 25. Eight months later 
she developed severe cellular rejection and haemo-
dialysis therapy was commenced. After a short period of 
haemodialysis she was established on peritoneal dialysis 
and treated with this modality for a period of just under 
two years. She was then transferred back to haemodialysis 
and was on this modality when she fell pregnant. 
At a follow-up visit she reported that her last menstrual 
period had been four months earlier. Laboratory testing 
confirmed that she was pregnant. Her dialysis prescription 
was changed in order for her to receive more than 20 
hours of dialysis per week. She was transferred to our 
dialysis unit for extended, nocturnal haemodialysis.
She was dialysed three times a week for 8 hours per 
session. Vascular access was obtained via a tunnelled 
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dialysis catheter in the right internal jugular vein. Blood flow 
rates were set at 200 ml/min and the dialysate flow rate at 
500 ml/min. Enoxaparin 40 mg was administered 
subcutaneously for anticoagulation prior to each dialysis 
session as she had previously had an allergic reaction to 
intravenous heparin. No adverse reactions or bleeding 
occurred. 
The patient’s blood pressure (BP) remained normal during 
the pregnancy with no need for any antihypertensive 
medication. BP on dialysis ranged from 90/41–135/72. 
Weight gain between dialysis sessions varied between 
1.6–3.5 kg. The patient had no residual renal function.
Ultrasound scanning was performed by a foetal medicine 
specialist one month after starting nocturnal dialysis. This 
indicated that she was 22 weeks pregnant. The patient was 
monitored every two weeks by her obstetrician. At 26 
weeks gestation, a repeat foetal assessment was performed. 
The foetus was estimated to weigh 800 g and was 
determined to be potentially viable. Thereafter, whilst the 
patient was on dialysis, the baby received continuous 
cardiotocograph monitoring, supervised by an obstetric 
nursing sister.
Serum biochemistry and haematology parameters were 
monitored monthly. The patient received regular intra-
venous iron sucrose infusions and an erythropoiesis-
stimulating agent was administered according to her 
haemoglobin level (Table 1). We were limited to a 
maximum dose of Mircera® (methoxy polyethylene glycol-
epoetin beta) of 200 µg monthly because of cost constraints. 
Despite regular monitoring and the treatment prescribed 
she remained anaemic and had a haemoglobin concentration 
of 8.3 g/dl at the time of delivery.
At 33 weeks gestation she developed preterm labour and 
was admitted to hospital. At 34 weeks she underwent an 
elective caesarean section. A baby boy was born, weighing 
1.86 kg. The baby’s APGAR scores were 5 and 7. He spent 
three days in the neonatal high care unit and a further six 
days in the neonatal nursery. When his weight was 2.0 kg, 
he was discharged home. The mother was discharged after 
four days and resumed her pre-pregnancy dialysis schedule 
of four-hour sessions three times a week. She has remained 
stable on dialysis one year later. Her son is alive and 
achieving his developmental milestones at one year.
dIscussIon
The review by Piccoli et al. [4] highlighted only two factors 
which correlated with foetal outcomes. These two factors 
related to the dialysis schedule: dialysis frequency and 
dialysis duration. The total number of hours of dialysis per 
week correlated significantly with foetal outcomes. 
Nocturnal or prolonged-duration chronic dialysis is not 
widely available in South Africa as it requires dedicated 
dialysis nursing staff and 24-hour availability of a nephrologist. 
Our access to prolonged dialysis treatments allowed us to 
deliver the desired dose of dialysis in three sessions per 
week, and at a lower total cost than would have been the 
case if we had used five or six of the standard 4-hour 
sessions weekly. 
Our multi-disciplinary team played an important part in the 
positive outcome. Assessing dry weight and preventing 
polyhydramnios is essential and this required regular review 
by the attending nephrologist. Our patient was reviewed 
regularly by her obstetrician and a foetal medicine specialist. 
Foetal monitoring while she was on dialysis was supervised 
by a trained obstetric nurse and should be recommended, 
although it does add to the overall costs. 
In conclusion, we have achieved a successful pregnancy 
outcome in a patient on chronic dialysis and highlighted our 
ability to maintain a pregnancy to viability with the support 
of a multidisciplinary team and using thrice-weekly, pro-
longed, nocturnal dialysis. This report also provides South 
African women of child-bearing age on dialysis with the 
hope that they may be able to contemplate a successful 
pregnancy.
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Successful pregnancy on chronic haemodialysis
table 1.  Summary of anaemia management during 
pregnancy.
Weeks of  
pregnancy
Dry weight 
(kg)
Haemoglobin 
(g/dl)
Iron sucrose 
dose
19–22 56.0 8.2 50 mg weekly
22–25 57.5 6.8 100 mg weekly
26–29 59.0 7.2 100 mg weekly
30–33 63.0 8.3 100 mg weekly
Mircera® 200 µg monthly was administered throughout. 
